Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis Children
Sponsor: Chinese University of Hong Kong
Summary
The study aims to evaluate the clinical efficacy and safety of the modified Qing-Ying Decoction (mQYD) for the treatment of subacute and chronic atopic dermatitis (AD) in children when compared to the placebo control through examining the clinical symptoms, quality of life, gut microbiome, and Chinese medicine body constitution. This is a parallel, randomized, placebo-controlled, double-blind clinical trial. Eligible subjects will be randomly allocated to receive oral mQYD granules or it's placebo granules. Subjects will have 12-week of treatment, and then a 4-week follow-up.
Official title: A Randomized Placebo-Controlled Clinical Trial of an Innovative Herbal Formula for Atopic Dermatitis in Children: Evaluations of Modified Qing-Ying Decoction on Efficacy and Gut Microbiome
Key Details
Gender
All
Age Range
4 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
64
Start Date
2020-09-10
Completion Date
2027-08
Last Updated
2026-07-30
Healthy Volunteers
No
Conditions
Interventions
Modified Qing-Ying Decoction
Herbal granules
Identical looking placebo
Placebo granules
Locations (1)
The Chinese University of Hong Kong
Hong Kong, Hong Kong